249 related articles for article (PubMed ID: 1399365)
1. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
Takami H; Ito K
Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
[TBL] [Abstract][Full Text] [Related]
2. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
4. [Measurement of plasma calcitonin gene-related peptide (CGRP) level in patients with thyroid disease].
Takami H; Shikata J; Ozaki O; Mimura T; Ito K
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):401-6. PubMed ID: 2359396
[TBL] [Abstract][Full Text] [Related]
5. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
6. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
8. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
Mirallié E; Iacobone M; Sebag F; Henry JF
Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
[TBL] [Abstract][Full Text] [Related]
9. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
[TBL] [Abstract][Full Text] [Related]
10. Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid.
Ohashi M; Natori S; Fujio N; Iguchi H; Nawata H
Horm Metab Res; 1990 Feb; 22(2):114-6. PubMed ID: 2323727
[TBL] [Abstract][Full Text] [Related]
11. PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinoma.
Raue F; Blind E; Grauer A
Henry Ford Hosp Med J; 1992; 40(3-4):296-8. PubMed ID: 1483876
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
13. Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules.
Hasselgren M; Hegedüs L; Godballe C; Bonnema SJ
Head Neck; 2010 May; 32(5):612-8. PubMed ID: 19691107
[TBL] [Abstract][Full Text] [Related]
14. Elevated basal calcitonin levels in a patient with a hurthle-cell carcinoma of the thyroid and neuroendocrine differentiation: report of a case.
Munitiz V; Martinez-Barba E; Riquelme J; Rodriguez JM; Piñero A; Parrilla P
Surg Today; 2005; 35(5):404-6. PubMed ID: 15864423
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of calcitonin level in the diagnosis and evaluation of the results of the treatment of medullary carcinoma of the thyroid gland].
Krassowski J; Słowińska-Srzednicka J; Gietka M; Sawicki A; Kokot F; Zgliczyński S
Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):757-9. PubMed ID: 2641802
[No Abstract] [Full Text] [Related]
16. Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies.
Kim JM; Chung KW; Kim SW; Choi SH; Min HS; Kim JN; Won WJ; Kim SK; Lee JI; Chung JH; Kim SW
Head Neck; 2010 Jan; 32(1):68-75. PubMed ID: 19536770
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.
Goltzman D; Potts JT; Ridgway RC; Maloof F
N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025
[No Abstract] [Full Text] [Related]
18. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement.
Bugalho MJ; Santos JR; Sobrinho L
J Surg Oncol; 2005 Jul; 91(1):56-60. PubMed ID: 15999359
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy.
Samaan NA; Schultz PN; Hickey RC
Horm Metab Res Suppl; 1989; 21():21-5. PubMed ID: 2807151
[TBL] [Abstract][Full Text] [Related]
20. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
